The study further elucidates the role of BNIP3 in inflammation in preeclampsia (PE) and proposes that BNIP3 could potentially serve as a target for the treatment of pregnancy-related diseases manifesting as placental inflammation, such as PE. This evidence concerns the gene BNIP3 and preeclampsia.